The life sciences industry continues to undergo significant transformation, with companies navigating through portfolio risks, pipeline challenges, public policy, and...
Read MoreThe life sciences sector, including biotechnology, pharmaceuticals, medical technology, and tools and diagnostics, continues to demonstrate resilience and innovation in...
Read MoreThe global data monetization market is forecast to grow from $3.47 billion in 2024 to $12.62 billion by 2032.[1] The...
Read MoreHealthcare has been quick to understand and apply artificial intelligence (AI) in many of its operational functions. It helps detect...
Read MoreHealthcare has been quick to understand and apply artificial intelligence (AI) in many of its operational functions. It helps detect...
Read MoreThe software industry is in the midst of a fundamental transformation in how value is monetized. Traditional software-as-a-service (SaaS) revenue...
Read More
SOURCE: ALM VANGUARD:
TRANSACTIONS - ACQUISITIONS CONSULTING
JUNE 2019 REPORT
“A&M has adeptly positioned itself across the restructuring and TAS businesses for a counter-cyclical market strategy, and with recent investments in scale and analytics is one of the non-Big Four providers most often mentioned.”
